CLINICAL TRIALS PROFILE FOR MANGANESE CHLORIDE TETRAHYDRATE
✉ Email this page to a colleague
All Clinical Trials for MANGANESE CHLORIDE TETRAHYDRATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04119843 ↗ | Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function | Recruiting | Ascelia Pharma AB | Phase 3 | 2020-02-19 | The overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in participants with known or suspected focal liver lesions and severe renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MANGANESE CHLORIDE TETRAHYDRATE
Condition Name
Clinical Trial Locations for MANGANESE CHLORIDE TETRAHYDRATE
Trials by Country
Clinical Trial Progress for MANGANESE CHLORIDE TETRAHYDRATE
Clinical Trial Phase
Clinical Trial Sponsors for MANGANESE CHLORIDE TETRAHYDRATE
Sponsor Name